Laurus Labs shares rally over 4% as Q1FY27 profit jumps 126% on strong CDMO growth

Economic Times · business

Laurus Labs reported a strong June-quarter performance, with net profit more than doubling and revenue rising 29% year-on-year, driven by robust growth in its CDMO business and affordable medicines portfolio.